An octapeptide inhibitor of paracellular permeability whose structure is derived from a protein (zonula occludens toxin) secreted by Vibrio cholerae for treatment of Coeliac disease. The directory classifies it as a discontinued API with a peptide source/manufacturing origin. Other names for this substance include Larazotida and glarazotidum. Its PubChem CID is 9810532.
Larazotide
| CAS No | 258818-34-7 |
|---|---|
| Molecular Formula | C32H55N9O10 |
| Molecular Weight | 725.80 g/mol |
| Synonyms | 2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
An octapeptide inhibitor of paracellular permeability whose structure is derived from a protein (zonula occludens toxin) secreted by Vibrio cholerae for treatment of Coeliac disease.
The listed CAS number is 258818-34-7.
The listed molecular formula is C32H55N9O10.
The listed molecular weight is 725.80 g/mol.
2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid.
The source lists Larazotida and glarazotidum.